Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06103370 · ClinicalTrials.gov registry record · NA

Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation

A NA study of HIV Infections and Opioid Use, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
360
Enrollment target
2
Study locations

NCT06103370 is a NA study of HIV Infections and Opioid Use that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 360 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (19% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06103370, a NA study of HIV Infections and Opioid Use, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
360 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to evaluate the effectiveness of a social network intervention to recruit people who inject drugs and their networks for HIV testing and linkage to HIV prevention and treatment services in Maryland. Study aims are to determine the effectiveness of a social network driven intervention to increase: * HIV testing (primary); * PrEP knowledge; * Uptake of HIV services and pre-exposure prophylaxis (PrEP); * Uptake of medication for opioid use disorder (MOUD) initiation. Eligible participants who access syringe service programs (SSPs) serving two counties in Maryland and their risk network members (NMs) will be recruited using an established network inventory and coupon recruitment method. When an index successfully recruits NMs, the index-NM cluster will be randomized to either a peer-educator intervention arm or an equal-attention control arm. Index participants randomized to the peer-educator intervention arm will complete a training program adapted with stakeholder input to context that emphasizes effective communication, frequent HIV testing, and awareness of evidence-based HIV prevention and treatment services. An important innovation to the network intervention will be training indexes to use and distribute HIV self-test kits and naloxone to their NMs. Index participants randomized to the equal-attention control arm will receive training sessions focused on the opioid overdose epidemic and will not include any training to serve as a peer educator. All participants (indexes and NMs) will complete study assessments at baseline and at 3 and 9 months. We will compare the peer-educator intervention group and the equal-attention control group on rates of HIV testing, knowledge of PrEP options and resources, and rates of initiation of HIV treatment, PrEP, and MOUD treatment since the previous assessment (past 3 or 6 months).

Interventions

  • BEHAVIORAL Peer-educator-based network

Study Locations (2)

Maryland

  • Johns Hopkins Hospital - Baltimore
  • Frederick County Health Department, Street Safe Program - Frederick

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2025-10-28
Est. Completion 2028-11
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT06103370

The ClinicalTrials.gov registry entry for NCT06103370 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (19% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Peer-educator-based network is the first listed.

NCT06103370 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT06103370 about?

NCT06103370 is a clinical study titled "Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation". The goal of this clinical trial is to evaluate the effectiveness of a social network intervention to recruit people who inject drugs and their networks for HIV testing and linkage to HIV prevention and treatment services in Maryland. Study aims are to determine the effectiveness of a social network ...

What is the current status of trial NCT06103370?

This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2025-10-28. Estimated completion is 2028-11.

What conditions does trial NCT06103370 study?

This clinical trial studies the following conditions: HIV Infections, Opioid Use, Substance Use Disorders, Drug Use, Addiction.

What interventions are being tested in trial NCT06103370?

The interventions under investigation include: Peer-educator-based network (BEHAVIORAL).

Who is sponsoring clinical trial NCT06103370?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06103370 being conducted?

This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.